Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2013
05/10/2013CA2854221A1 Novel process for the preparation of acylguanidines and acylthioureas
05/09/2013US20130116431 Novel HSP90 Inhibitor
05/09/2013US20130116284 Lipoic acid and nitroxide derivatives and uses thereof
05/09/2013US20130116264 Novel Hetaryl (thio)carboxamide Compounds for Controlling Invertebrate Pests
05/09/2013US20130116253 Novel HSP90 Inhibitor
05/09/2013US20130116252 Novel HSP90 Inhibitor
05/09/2013US20130116251 Novel HSP90 Inhibitor
05/09/2013US20130116240 Indole compounds and pharmaceutical use thereof
05/09/2013US20130116231 Tyrosine kinase inhibitors
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116216 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
05/09/2013US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
05/09/2013US20130115312 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115311 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115193 Hepatitis C Virus Inhibitors
05/09/2013US20130113367 Heterocyclic compound and organic light-emitting device including the same
05/09/2013US20130112948 Heterocyclic compound and organic light-emitting diode including the same
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2589595A1 Agent for treating hcv infection
05/08/2013EP2589591A1 Compound with carbazole ring structure and organic electroluminescent element
05/08/2013EP2588466A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
05/08/2013EP2588453A1 Compositions and methods for modulating the wnt signaling pathway
05/08/2013CN103097377A New crystalline forms of n-[2-[[(2,3-difluoropheny)methyl) thio]-6{[(1r,2s)-2,3-dihydroxy-1-methylpropyl]oxy} 4-pyrimidinyl]-1-azetidinesulfonamide
05/08/2013CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2
05/08/2013CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/08/2013CN103087045A Benzimidazole heterocyclic compound, pharmaceutical composition and application thereof
05/08/2013CN103087044A Method for preparing benzimidazole heterocyclic compound
05/08/2013CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof
05/08/2013CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor
05/08/2013CN103086953A Heterocyclic compound and organic light-emitting device including the same
05/08/2013CN101970404B Novel method for the production of sulphonylpyrroles as hdac inhibitors
05/08/2013CN101821243B Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
05/08/2013CN101801955B Pyrimidyl cyclopentanes as akt protein kinase inhibitors
05/08/2013CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
05/08/2013CN101578265B Sulfonamide derivatives as chymase inhibitors
05/08/2013CN101454308B Process for preparing heterocyclic derivatives
05/07/2013US8436036 Diaryl ethers
05/07/2013US8436034 Carboxamide compounds and their use as calpain inhibitors
05/07/2013US8436005 Macrocyclic pyrimidine derivatives
05/07/2013US8435990 Dihydropyrimidone amides as P2X7 modulators
05/07/2013US8435984 Tertiary amine substituted peptides useful as inhibitors of HCV replication
05/07/2013US8435983 Conformationally restrained epothilone analogues as anti-leukemic agents
05/07/2013US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives
05/07/2013US8435976 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
05/07/2013CA2694911C Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
05/07/2013CA2574827C 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
05/02/2013WO2013063492A1 Novel compositions and methods for treating cancer
05/02/2013WO2013063468A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
05/02/2013WO2013063458A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
05/02/2013WO2013063221A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
05/02/2013WO2013062294A2 Improved preparation method for mitiglinide calcium
05/02/2013WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element
05/02/2013WO2013062043A1 4-aminocarbazole compound and use of same
05/02/2013WO2013062027A1 Azole derivative
05/02/2013WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity
05/02/2013WO2013061850A1 Organic electroluminescence element, display device, and lighting device
05/02/2013WO2013061297A1 Pyridazine Derivatives Useful in Therapy
05/02/2013WO2013061081A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013WO2013060751A1 Novel pyrazine derivatives
05/02/2013WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
05/02/2013WO2013002660A3 Process
05/02/2013WO2012107434A8 Insecticidal compounds
05/02/2013US20130109856 Novel process for the preparation of acylguanidines and acylthioureas
05/02/2013US20130109706 Quinazoline-based t cell proliferation inhibitors
05/02/2013US20130109695 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
05/02/2013US20130109684 Grp94 inhibitors
05/02/2013US20130109678 Radioprotector compounds and methods
05/02/2013US20130109669 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
05/02/2013US20130109665 Novel pyrazine derivatives
05/02/2013US20130105767 Carbazole derivatives and organic light emitting diodes comprising the same
05/02/2013CA2853826A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
05/02/2013CA2853729A1 Novel compositions and methods for treating cancer
05/02/2013CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
05/02/2013CA2853485A1 Compounds for inflammation and immune-related uses
05/02/2013CA2853455A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
05/02/2013CA2853401A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013CA2853231A1 Pyridazine derivatives useful in therapy
05/02/2013CA2853227A1 Azole derivative
05/02/2013CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity
05/02/2013CA2851930A1 Novel pyrazine derivatives
05/01/2013EP2586779A1 Process for the preparation of moxonidine
05/01/2013EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors
05/01/2013EP2585440A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia
05/01/2013EP2585437A2 Thioacetate compounds, compositions and methods of use
05/01/2013CN103080109A Deuterium-enriched heterocyclic compounds as kinase inhibitors
05/01/2013CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
05/01/2013CN103080103A Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
05/01/2013CN103080094A P2X4 receptor antagonist
05/01/2013CN103080093A Indazole compounds and their uses
05/01/2013CN103079406A Fungicidal pyrazoles
05/01/2013CN103073537A Synthesis process of candesartan cilexetil
05/01/2013CN103070868A IDO inhibitor containing NH-1,2,3-triazole and preparation method thereof
05/01/2013CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof
05/01/2013CN101709060B F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof
05/01/2013CN101657430B Organic compounds and their uses
05/01/2013CN101479255B C-MET protein kinase inhibitors for the treatment of proliferative disorders
05/01/2013CN101365687B Piperazine compounds with a herbicidal action
05/01/2013CN101341134B 嘧啶衍生物 Pyrimidine derivatives
05/01/2013CN101321750B Multimeric magnetic resonance contrast agents
04/2013
04/30/2013USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 626